
Botulinum toxin A with cast treatment for idiopathic toe-walking does not improve outcome

Botulinum toxin A with cast treatment for idiopathic toe-walking does not improve outcome
Botulinum toxin a does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial
J Bone Joint Surg Am. 2013 Mar 6;95(5):400-7. doi: 10.2106/JBJS.L.00889Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
OE EXCLUSIVE
Dr.Engstrom discusses the use of Botulinum toxin A with cast treatment for idiopathic toe-walking
Synopsis
52 children were randomized to examine whether the addition of botulinum toxin A prior to cast treatment was effective in managing idiopathic toe-walking. Patients were treated with either 4 weeks of below-the-knee casts alone or 4 weeks of cast treatment 1 to 2 weeks following botulinum toxin A injections into the calves. The assessment at 12 months revealed that botulinum toxin A injections with...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.